Whole body vibration and treadmill training in Parkinson’s disease rehabilitation: effects on energy cost and recovery phases
- 189 Downloads
Although physical treatment is recognized as being beneficial for patients with Parkinson’s disease (PD), there is scant literature on the type of rehabilitation program most useful for patients with PD. The aim of the present study was to investigate the effects of two different training protocols (aerobic treadmill training, AER and whole body vibration training, WBVT) on energy cost and adaptations after exercise and recovery phases, by means of the oxygen consumption measurement and the assay of metabolic biochemical substrates.
Twenty male patients with idiopathic Parkinson’s disease, aged 51–66 years, were enrolled. Patients were randomly assigned to the training groups. The total work time was 20 min per group for 4 weeks, four times a week. In both groups, training intensity was monitored by the ratings of perceived exertion (RPE). Workload was gradually increased until patients worked up to the exertion level of 13 to 15 on the 20-point Borg scale RPE. The outcome measures were oxygen consumption, free fatty acid (FFA), and amino acid (AA) levels.
The oxygen consumption during exercises does not show significant differences between the two training groups. Instead, only in the AER group, excess post-exercise oxygen consumption measurements increased significantly (p < 0.01) as well as FFA availability (p < 0.01).
The WBVT does not appear to require a long time of recovery and leads to less feeling of fatigue, whereas AER needs an appropriate recovery time after the training session.
KeywordsParkinson’s disease Rehabilitation Vibration Excess post-exercise oxygen consumption Amino acids Free fatty acids
Compliance with ethical standards
The study was approved by the local Ethical Committee of the Azienda Ospedaliero-Universitaria Pisana in accordance with the code of Ethics of the World Medical Association (Declaration of Helsinki). Written informed consent was obtained prior to participation in the study and after explanation of the protocol.
Conflict of interest
On behalf of all authors, the corresponding author states that there is no conflict of interest.
- 1.Italian Society of Clinical Neurophysiology; Italian Neurological Society; Guidelines for the Treatment of Parkinson’s Disease 2002 (2003) Treatment of Parkinson’s disease. Neurol Sci 24 Suppl 3:S165–S213Google Scholar
- 5.Drużbicki M, Guzik A, Przysada G, Kwolek A, Brzozowska-Magoń A, Sobolewski M (2016) Changes in gait symmetry after training on a treadmill with biofeedback in chronic stroke patients: a 6-month follow-up from a randomized controlled trial. Med Sci Monit 22:4859–4868CrossRefPubMedPubMedCentralGoogle Scholar
- 15.Goetz CG, Tilley BC, Shaftman SR, Stebbins GT, Fahn S, Martinez-Martin P, Poewe W, Sampaio C, Stern MB, Dodel R, Dubois B, Holloway R, Jankovic J, Kulisevsky J, Lang AE, Lees A, Leurgans S, LeWitt PA, Nyenhuis D, Olanow CW, Rascol O, Schrag A, Teresi JA, van Hilten JJ, LaPelle N, for the Movement Disorder Society UPDRS Revision Task Force (2008) Movement disorder society-sponsored revision of the unified Parkinson’s disease rating scale (MDSUPDRS): scale presentation and clinimetric testing results. Mov Disord 23:2129–2170CrossRefPubMedGoogle Scholar
- 21.Fisher BE, Wu AD, Salem GJ, Song J, Lin CH, Yip J, Cen S, Gordon J, Jakowec M, Petzinger G (2008) The effect of exercise training in improving motor performance and corticomotor excitability in people with early Parkinson’s disease. Arch Phys Med Rehabil 89:1221–1229CrossRefPubMedPubMedCentralGoogle Scholar
- 34.Wolfe RR, Klein S, Carraro F, Weber JM (1990) Role of triglyceride-fatty acid cycle in controlling fat metabolism in humans during and after exercise. Am J Phys 258:E382–E389Google Scholar
- 38.Paul J, Kuruvilla KP, Mathew J, Kumar P, Paulose CS (2011) Dopamine D1 and D2 receptor subtypes functional regulation in cerebral cortex of unilateral rotenone lesioned Parkinson’s rat model: effect of serotonin dopamine and norepinephrine. Parkinsonism Relat Disord 17:255–259CrossRefPubMedGoogle Scholar
- 40.Gökçe Çokal B, Yurtdaş M, Keskin Güler S, Güneş HN, Ataç Uçar C, Aytaç B, Durak ZE, Yoldaş TK, Durak İ, Çubukçu HC (2017) Serum glutathione peroxidase, xanthine oxidase, and superoxide dismutase activities and malondialdehyde levels in patients with Parkinson’s disease. Neurol Sci 38:425–431CrossRefPubMedGoogle Scholar